<< Obesity related health complications more dangerous than risks associated with bariatric surgery | Northwestern Memorial HealthCare completes its formal plans to affiliate with Lake Forest Hospital >>

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | हिन्दी | Русский | Svenska | Polski

Global market report on CNS drugs

Published on January 30, 2010 at 1:19 AM · No Comments

Reportlinker.com announces that a new market research report is available in its catalogue:

CNS Therapeutics - A World Market Review

http://www.reportlinker.com/p0164268/CNS-Therapeutics---A-World-Market-Review.html

While the available CNS therapies can slow down deteriorating condition of patient, the clinical pipeline boasts of new drug classes with potential to stop or reverse the disease's progression. Continuing switch over of patients from typical or traditional anti-psychotics to expensive and safer atypical anti-psychotics drugs, such as Zyprexa, Risperdal and Geodon is driving the market forward. Global market for anti-depressants, a dominant product category of CNS therapeutics is on a decline, succumbed by increasing generic competition, loss of patent protection of key drugs, and increased risk of suicidal tendencies among adolescents.

These and other market data and trends are presented in "CNS Therapeutics: World Market Review" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses

SOURCE Reportlinker

2bc44bfb-addf-4da9-bc47-57eee476e9ed|0|.0

Posted in: Pharmaceutical News

Tags: Abilify, Antidepressant, Anxiety, Bipolar Disorder, Depression, Drug Delivery, Epilepsy, Insomnia, Migraine, Multiple Sclerosis, Pfizer, Prophylaxis, Restless Legs Syndrome, Risperdal, Schizophrenia, Sleep, Tuberculosis, Zyprexa

Related posts

Overeating may increase risk of MCI among the elderlyNew research suggests that consuming between 2,100 and 6,000 calories per day may double the risk of...
FDA approves INNOPHARMA's ANDA for olanzapine injectionINNOPHARMA LLC announced today FDA approval of its Abbreviated New Drug Application (ANDA) for olanz...
Middle-aged woman with RLS more likely to develop hypertensionIf you're a middle-aged woman with Restless Legs Syndrome, you may have a higher risk of developing ...
Seven-year study finds Group B strep as main cause of newborn bacterial meningitisThe Group B Streptococcus is still the most common cause of bacterial meningitis in newborns, conclu...
Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billionJohnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease ...
Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), ...
FDA approves LPI's Perindopril Erbumine tabletsLupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the U.S. ...
Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2BDecision Resources, one of the world's leading research and advisory firms for pharmaceutical and he...
BioMedReports electronic newsletter releases an article about Biomagnetics DiagnosticsBiomagnetics Diagnostics Corp., a producer of revolutionary diagnostic systems and technology for ma...
FDA extends review period for Endo Pharmaceuticals' testosterone undecanoateEndo Pharmaceuticals announced today that it has been informed by the U.S. Food and Drug Administrat...
CHI's first symposium to increase the understanding of its role in performing human immunologic studiesNIH’s National Heart, Lung and Blood Institute’s CENTER FOR HUMAN IMMUNOLOGY (CHI) announces the fir...
Link between sleep disorders, diet, exercise and technology use in adolescentsAccording to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd ...
Metastatic bone disease patients can walk in Lazarus' footstepsOsteoplasty - a highly effective minimally invasive procedure to treat the painful effects of metast...
Improving cancer diagnosis and support services for Asian patientsThere is a need to remove the major ethnic inequalities which still exist in access to cancer servic...
New findings on vitamin DSurprising findings by Queen's University researchers have shed new light on how the 'sunshine vitam...
Eating fish keeps mind as well as heart, happy and healthyAccording to researchers in the U.S., Omega-3 polyunsaturated fatty acids may have more of an influe...
A third of U.S. adults use some form of complementary and alternative medicineAccording to a new nationwide government survey, 36 percent of U.S. adults aged 18 years and over us...
Public Health Advisory for medical professionals with patients on anti-depression medicationOn Monday, March 22, 2004 the Food and Drug Administration issued a Public Health Advisory for medic...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.